Assyro AI

FDA Orange Book · active-ingredient family

Carisoprodol

Carisoprodol is approved as 2 brand and 24 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SOMA · NDA 011792

2

Brand (NDA)

24

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, tablet

ProductApplicantApplicationTEApproved
SOMARLD×3MYLAN SPECIALITY LPNDA 011792Approved Prior to Jan 1, 1982
RELASCHERINGNDA 012155Approved Prior to Jan 1, 1982

Generic (ANDA) products (24)

ProductApplicantApplicationTEApproved
CARISOPRODOLPOINTVIEW HLDINGSANDA 211789AAOct 20, 2021
CARISOPRODOL×2MPP PHARMAANDA 207237ABMay 11, 2017
CARISOPRODOL×2AUROBINDO PHARMAANDA 040792ABNov 08, 2016
CARISOPRODOL×2STRIDES PHARMAANDA 205513Nov 12, 2015
CARISOPRODOL×2HERITAGEANDA 205126ABJul 08, 2015
CARISOPRODOLNATCOANDA 090988AAOct 28, 2014
CARISOPRODOLORIENT PHARMA CO LTDANDA 205085AAOct 28, 2014
CARISOPRODOLSCIEGEN PHARMSANDA 203374AAJan 27, 2014
CARISOPRODOLINGENUS PHARMS LLCANDA 040823AAOct 22, 2008
CARISOPRODOLSUN PHARM INDS LTDANDA 040755Feb 27, 2007
CARISOPRODOLACCELRX LABSANDA 040576AAJun 07, 2005
CARISOPRODOLABLEANDA 040421Jun 21, 2001
CARISOPRODOLEPIC PHARMA LLCANDA 040397Sep 21, 2000
CARISOPRODOLCHARTWELL RXANDA 040245AASep 08, 1997
CARISOPRODOLOXFORD PHARMSANDA 040188AAMar 07, 1997
CARISOPRODOLWATSON LABSANDA 040152Dec 03, 1996
CARISOPRODOLHIKMA INTL PHARMSANDA 040124Jan 24, 1996
CARISOPRODOLSUN PHARM INDUSTRIESANDA 089346Oct 17, 1991
CARISOPRODOLSENORES PHARMSANDA 081025AAApr 13, 1989
CARISOPRODOLPIONEER PHARMSANDA 089390Oct 13, 1988
CARISOPRODOLSANDOZANDA 089566Aug 30, 1988
CARISOPRODOLWATSON LABSANDA 087499AAApr 20, 1982
CARISOPRODOLWATSON LABSANDA 085433Approved Prior to Jan 1, 1982
CARISOPRODOLWATSON LABS TEVAANDA 086179Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Carisoprodol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.